SABRINA DEPUE: Open Payments
NPI 1326774902 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 71 payments from 40 companies in 2025. Trend: 2023 $467 · 2024 $1,523 · 2025 $1,543
Food & beverage: $1,375Education: $167
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. | 1 | $108 |
| Novartis Pharmaceuticals Corporation | 6 | $107 |
| Gilead Sciences, Inc. | 1 | $99 |
| AstraZeneca Pharmaceuticals LP | 2 | $86 |
| Janssen Biotech, Inc. | 4 | $81 |
| SOBI, INC | 4 | $80 |
| BeOne Medicines USA, Inc. | 4 | $76 |
| ABBVIE INC. | 4 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Incyte Corporation | 3 | $54 |
Products named: REZLIDHIA, Trodelvy, IMFINZI, Nubeqa, BRUKINSA, VENCLEXTA, Gamifant, LUTATHERA.
Industry payments across PA — which companies pay providers there.
